The plaintiff in a putative class action against Revlon Group Inc. includes in her complaint a letter from Almay, Inc. to FDA – more than four decades ago – as evidence that “hypoallergenic” Almay products are falsely advertised.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?